Tag: IBD-
Clinically Active IBD Linked to Adverse COVID-19 Outcomes
Measure indicating greater activity of IBD independently linked to ICU/ventilation/death and hospitalization among patients 50 years or younger
Intestinal Ultrasound Informs Management of IBD
In 60 percent of patients, IUS had impact on disease management, with change in medication in 47.8 percent
Prevalence of Primary Sclerosing Cholangitis in IBD Examined
Global prevalence of primary sclerosing cholangitis ranges from 0.96 percent in Crohn disease to 2.47 percent in ulcerative colitis
Outcome Measure Developed for Crohn’s Perianal Fistula
Crohn's Anal Fistula QoL has good internal consistency, excellent stability, good responsiveness and construct validity
VTE Risk Up for Children With Inflammatory Bowel Disease
Venous thromboembolism occurred less often for those with Crohn disease versus ulcerative colitis
Ultra-Processed Food May Up Risk for Inflammatory Bowel Disease
Higher risk for developing IBD associated with higher intake of ultra-processed foods, such as soft drinks, salty snacks, processed meat
Risk for VTE Up for IBD Patients Infected With SARS-CoV-2
Odds of VTE increased 8.15-fold according to models adjusting for recent hospitalization and steroid exposure
Risk for Adverse Events Not Increased After COVID-19 Vaccine in IBD
Frequency of adverse events was higher for those younger than 50 years, individuals with prior COVID-19 history
Infliximab May Reduce Immunogenicity to SARS-CoV-2 Vaccine
Antibody concentrations lower in infliximab-treated individuals with IBD receiving single dose of BNT162b2 or ChAdOx1 nCoV-19 vaccine
2001 to 2018 Saw Increase in Estimated Prevalence of IBD in Seniors
Increase higher among non-Hispanic Blacks, while prevalence was consistently highest for non-Hispanic Whites
